Other OTC Pharmaceuticals - APAC | Statista Market Forecast

In APAC, the revenue generated in the Other OTC Pharmaceuticals market amounts to US$8.52bn in 2024.
It is projected to experience annual growth of 1.74% (CAGR 2024-2028).
When compared globally, the United States leads in revenue generation with US$7.17bn in 2024.
In terms of per person revenues, US$1.99 is generated in 2024.
In APAC, the demand for Other OTC Pharmaceuticals is driven by the increasing focus on self-medication and the availability of a wide range of products in the market.

Definition:
The Other OTC Pharmaceuticals market encompasses a range of non-prescription pharmaceuticals and medical products that are available for purchase without a prescription. This category includes various products that are not explicitly covered in other submarkets, such as oral treatments, ear drops, female contraception, smoking cessation aids, hair growth products, and more. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The market for Other OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Oral treatments
Ear Drop
Female Contraception
Smoking Cessation Aids
Hair Growth Product

Prescription Medications
Medical Equipment and Devices

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.